吉林包皮美容多少钱吉林包皮手术哪家医院专业,吉林性功能障碍有治吗,吉林那个男科医院好啊,吉林阳痿治疗的方法,吉林割包皮环切术价格,吉林医院小便有血是怎么回事,吉林前列腺泌尿专科医院

BEIJING, July 17 (Xinhua) -- China's land prices in 105 cities rose 1.87 percent on average in the second quarter over the first, but the rate of growth slowed, the China Urban Land Price Dynamic Monitor, a land price information provider, announced Sunday. < In the second quarter, land price for business properties averaged 5,506 yuan (about 847 U.S. dollars) per square meter, up 2.77 percent from the previous quarter. The growth rate slowed by 0.56 percentage points.Land price for residential properties averaged 4,443 yuan per square meter, up 2.17 percent. The growth slowed by 0.27 percentage points. The price for industrial uses, meanwhile, was up 1.13 percent to reach 645 yuan per square meter. The growth fell 0.3 percentage points.The country's three most prosperous regions, the Yangtze River Delta Region, Pearl River (Zhujiang) Delta Region, and the Bohai Rim, all reported slower land price growth in the second quarter.

MOSCOW, Sept. 21 (Xinhua) -- A Russian Proton-M carrier rocket carrying a military spacecraft blasted off early Wednesday from the Baikonur space center in Kazakhstan, the first launch since a series setbacks of Russian rocket launch in August.Colonel Alexei Zolotukhin, spokesman of the Russian Space Forces, told reporters that the successful launch took place at 02:47 Moscow time (2247 GMT Tuesday) as scheduled."The spacecraft is scheduled to separate from the Briz-M booster at 11:48 Moscow time (0748 GMT)," Zolotukhin said.The military spacecraft delivered by the Proton-M belongs to the Russian Defense Ministry.Local reports said the Wednesday launch was originally planned for Aug. 31, but was postponed due to an investigation into a failed launch of a Proton-M rocket carrying an Express-AM4 satellite on Aug. 18.After the failure, Russia decided to suspend launches of rocket Proton-M pending the outcome of a probe into the accident.On Aug. 24, a Progress M-12M cargo ship also failed to reach the orbit due to a rocket malfunction. Russia delayed the launch of next manned spaceship to the International Space Station (ISS).

BEIJING, Aug. 3 (Xinhuanet) -- The first man in Britain who received a complete plastic heart is allowed to leave hospital and live a relatively normal life at home.Matthew Green, 40, who was dying from arrhythmogenic right ventricular cardiomyopathy, was awaiting a transplant when his condition became so bad that the doctors at Papworth Hospital, the world renowned heart center near Cambridge, decided to give him Britain’s first ever full artificial heart.During a six-hour operation on June 9, 2011, surgeons replaced Mr Green's damaged heart with the device which will serve the role of muscles and ventricles.Unlike previous artificial hearts, they have usually only replaced parts of the organ, the new one is powered by a pump which sits outside the body and can be held in a backpack or shoulder bag.All Mr Green has to do is replace the batteries in the pump every few hours and the heart should last up to three years.Transplant milestones1964 US National Institutes of Health starts artificial heart programme.1966 First transplant of partial mechanical heart, to assist pumping of ventricle.1969 Texas man receives first total artificial heart transplant. After 64 hours on the mechanical device received a donor organ, but died within two days.1982 Artificial heart designed by Utah University doctor Robert Jarvik implanted into man who survived for 112 days.2001 First surgical implant of internally powered artificial heart, which was charged via transduction through skin.

WELLINGTON, July 29 (Xinhua) -- Scientists from around the world will gather on the east coast of New Zealand next week to discuss proposals to study "silent" earthquakes by drilling into the seabed.Silent quakes, also known as slow slip events, occur on the boundaries of the earth's tectonic plates, where one plate dives under another in areas known as subduction zones, and are slower than normal quakes, taking weeks or months to occur rather than seconds, and are rarely felt on the surface.About 70 scientists from 10 countries will convene in the city of Gisborne, which lies near the site of a major fault line and where scientists first identified silent earthquakes in 2002.Slow-slip events were first discovered with the advent of new measurement technologies on the west coast of Canada about 15 years ago and have since been recorded at about a dozen locations around the world, including four sites around New Zealand, said a spokesperson for New Zealand's Institute of Geological and Nuclear Sciences (GNS Science).About eight slow-slip episodes have occurred under Gisborne since 2002 at roughly two-year intervals.Scientists have proposed numerous theories to explain the phenomenon, but testing the theories is difficult as silent quakes happen many kilometers below ground."The best way to understand the true cause of slow-slip events is to drill into and sample the area on the plate boundary fault where they are known to occur, and monitor a whole range of physical and chemical properties at the plate interface," said Laura Wallace, of GNS Science.

SINGAPORE, Sept. 7 (Xinhua) -- Singapore scientists have found possible new ways to treat a type of aggressive breast cancer that is unresponsive to current forms of treatment, local broadcaster Channel NewsAsia reported on Wednesday.The team of scientists at the Genome Institute of Singapore ( GIS) and National University of Singapore (NUS), led by GIS senior group leader Qiang Yu, found that the enzyme EZH2 acts by inhibiting genes that stop the growth of tumors in the body.The insights could open the door to developing more effective treatment for fast spreading breast cancers, especially the estrogen receptor-negative breast cancer that is common all over the world.It was also found that through EZH2, cancer is promoted in the body by activating specific genes that impact breast cancer progression and cancer stem cell self-renewal.Yu said the new understanding on how EZH2 works as a cancer- causing gene in breast cancer has important therapeutic implication."The results suggest that small molecule drugs that block enzyme activity of EZH2 may not work for cancers caused by EZH2's activation genes," Yu said.Currently pharmaceutical companies have been developing drugs only to the block EZH2 enzyme activity so that tumor suppressers can perform their protective role in blocking cancer growth.Researchers said the next step would be to develop biomarkers to identify tumors with EZH2.This step would enable better treatment methods, with one of options being the development of therapies that shut down EZH2 completely and not just inhibit its enzymatic function.The findings have been published on the journal Molecular Cell.